Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Concur Matches Estimates – Analyst Blog

Zacks Market Commentaries (November 19th, 2009) Writes:
Concur Technologies Inc (CNQR) reported 2009 fourth quarter earnings per share from continuing operations of 14 cents, matching the Zacks Consensus Estimate.  Concur reported total revenue for the fourth quarter of fiscal 2009 of $64.8 million, driven by subscription revenue. Total revenue for the quarter was also up 13% from the year-ago quarter. Total subscription revenue was $62.9 million for the fourth quarter of fiscal 2009, up 13% compared to the year-ago quarter, and up 3% sequentially.  Bookings were exceptionally strong as the company signed more business in the fourth quarter than in any of the quarter in the company's history. Looking ahead, it expects the demand environment to remain solid throughout the fiscal year.  The long-term growth rate for both revenue and earnings is driven by new customer additions and cost selling of new services. The company signs more new business in the most ...

DrStockPick.com Stock Report! 10/13/09, CVAT, MDT, TXT, NENG, CPWR, ETH

Dr. Stock Pick (October 13th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_______________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_______________________________________

Tuesday October 13, 2009

DrStockPick.com Stock Report!

**************************************************************

Cavitation Technologies, Inc. (OTC Bulletin Board: CVAT) has announced that it has filed PCT patent applications for new International Patent protections for its Nano Cavitation Technologies

Medtronic, Inc. (NYSE: MDT), announced today the initiation of a feasibility study of an interventional treatment for erectile dysfunction (ED) that uses a specially-designed drug-eluting stent system. The study, called ZEN (Zotarolimus-Eluting Peripheral Stent System for the Treatment of Erectile Dysfunction in Males with Sub-Optimal Response to PDE5 Inhibitors), is being

...
Tags for this Post:
10G ATCA Solutions, application performance management, Cavitation Technologies Inc., cloud computing era, Commercial Communications, Compuware Corporation;, Design Center, Development and Engineering Center, Director of Marketing, Dr Stock Pick, dti, Energetic Materials Research and Testing Center, erectile dysfunction, Ethan Allen, Investing Lessons, Jeff Hudgins, Jeff Marden, Las Vegas, Las Vegas Design Center, manager, Medtronic Inc, Nano Cavitation Technologies, NEI, New Mexico, PDE5, Program Manager, Robert Pettigrew, RPG, senior architect and technologist, Socorro, Stocks to Watch, Textron Defense Systems, Textron Inc, Textron Systems, treatment for erectile dysfunction, Treatment of Erectile Dysfunction, U.S. Army Tank Automotive Research, U.S. Food and Drug Administration, United States, vice president of marketing, World Market Center Las Vegas

Concur Partners Southwest – Analyst Blog

Zacks Market Commentaries (August 25th, 2009) Writes:
Concur Technologies Inc. (CNQR) signed a content agreement with Southwest Airlines (LUV) giving Concur® Travel & Expense client direct access to Southwest Airlines fares and schedules.

This agreement provides Concur clients with direct access to Southwest inventory options. It provides Concur clients with direct access to content from Southwest, including:

Integrated display with enhanced functionality such as live availability and last seat inventory Pricing functionality that will support all pricing rules, fare rules and return of ticket number Support for low fare searches that return the lowest fares available Booking and ticketing that supports the Loyalty/Rapid Rewards member number A wide range of additional functional benefits, including deferred ticketing, cancel reservation, retrieve reservation and exchange funds towards the purchase of new itineraries. Through Concur® Connect – the global program that connects suppliers from around ...

Compuware Hopeful; Stay Cautious – Analyst Blog

Zacks Market Commentaries (December 4th, 2008) Writes:
Compuware Corporation (CPWR) provides software products and professional services to many of the largest users of information systems in the world. The company employs over 7,500 professionals across the globe, with 99 offices in 31 countries, and serves more than 70% of the Fortune 500 companies.Compuware continues to transform its business and expects that restructuring activities undertaken in fiscal 2008 will reduce operating costs by approimately $100 million on an annualized basis. In the first half of fiscal 2009 (ended September), CPWR identified new annualized reductions of $55 million and are targeting $80 million for 2009. Management remains optimistic that it will achieve the financial guidance it had set for FY:09. We continue to rate the stock a Hold with a target price of $6.25.Read the full analyst report on CPWR "CPWR" Free Stock Analysis: Buy? Sell? ...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.